Announcements Trials
Browse Landscape

Phase

Phase 4 4

Status

Terminated 2Unknown 1Completed 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 4

Conditions

Esophageal Neoplasms 4

Interventions

Oxaliplatin 1439Fluorouracil 1319Capecitabine 1114Gemcitabine 1057Leucovorin 939Bevacizumab 847Irinotecan 830Cisplatin 676Radiotherapy 560Cetuximab 482pembrolizumab 435Paclitaxel 401Drug Therapy 358Nivolumab 350130-nm albumin-bound paclitaxel 329Docetaxel 290Sorafenib 288S 1 (combination) 279Folfox protocol 266Albumin-Bound Paclitaxel 263Surgical Procedures, Operative 258lenvatinib 222sintilimab 218tislelizumab 214durvalumab 212regorafenib 209Magnetic Resonance Spectroscopy 205apatinib 204Radiosurgery 204Neoadjuvant Therapy 190

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
sodium glycididazole × Gastrointestinal × Clear all
NCT02721550 2019-10-11

A Trial of CMNa Combined With Preoperatie Concurrent Chemoradiotherapy for Locally Advanced ESCC

Shandong Cancer Hospital and Institute

Phase 4 Terminated
2 enrolled
Gastrointestinal

Esophageal Neoplasms

NCT02721563 2019-10-11

A Trial of CMNa Combined With Definitive Concurrent Chemoradiotherapy for Locally Advanced ESCC

Shandong Cancer Hospital and Institute

Phase 4 Completed
77 enrolled
Gastrointestinal

Esophageal Neoplasms

NCT02721576 2019-10-11

A Trial of CMNa Combined With Concurrent Chemoradiotherapy for Locally Recurrent ESCC

Shandong Cancer Hospital and Institute

Phase 4 Terminated
8 enrolled
Gastrointestinal

Esophageal Neoplasms

NCT00642239 2008-05-14

A Clinical Trial of a Radiation Sensitizer in Radiochemotherapy for Thoracic Esophageal Squamous Carcinoma

Shandong Luye Pharmaceutical Co., Ltd.

Phase 4 Unknown
48 enrolled
Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡